Similar Search Results

The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England

Meng, Yang; Hertel, Nadine; Ellis, John; Morais, Edith; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 8, pp. 1163-1172

Persistent link: https://www.econbiz.de/10011948237

Pricing implications of non-marginal budgetary impacts in health technology assessment : a conceptual model

Howdon, Daniel; Lomas, James - 2017

Persistent link: https://www.econbiz.de/10011751722

Is it too expensive to fight cancer? : analysis of incremental costs and benefits of the Croatian National Plan Against Cancer

Vrdoljak, Eduard; Sekerija, Mario; Plestina, Stjepko; … - In: The European journal of health economics 22 (2021) 3, pp. 393-403

Persistent link: https://www.econbiz.de/10012488623

Economic burden of stroke : a systematic review on post-stroke care

Rajsic, S.; Gothe, Holger; Borba, H. H.; Sroczynski, G.; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 1, pp. 107-134

Persistent link: https://www.econbiz.de/10011998088

Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations : a scoping review

Fischer, Claudia; Mayer, Susanne; Perić, Nataša; … - In: Health economics review 12 (2022) 1, pp. 1-13

Background: Valuation is a critical part of the costing process in health economic evaluations. However, an overview of specific issues relevant to the European context on harmonizing methodological requirements for the valuation of costs to be used in health economic evaluation is lacking. We...

Persistent link: https://www.econbiz.de/10013329785

Are costs derived from diagnosis-related groups suitable for use in economic evaluations? : a comparison across nine European countries in the European healthcare and social cost d...

Špacírová, Zuzana; Epstein, David; Espin, Jaime - In: The European journal of health economics 23 (2022) 9, pp. 1563-1575

Persistent link: https://www.econbiz.de/10013463124

Does the inclusion of societal costs change the economic evaluations recommendations? : a systematic review for multiple sclerosis disease

Rodríguez-Sánchez, Beatriz; Daugbjerg, S.; … - In: The European journal of health economics 24 (2023) 2, pp. 247-277

Persistent link: https://www.econbiz.de/10014327973

Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity : a systematic review of economic evaluations

Jordan, Karen; Fawsitt, Christopher G.; Carty, Paul G.; … - In: The European journal of health economics 24 (2023) 4, pp. 575-590

Persistent link: https://www.econbiz.de/10014328039

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions : a comparison of five European countries

Mokri, Hamraz; Kvamme, Ingelin; De Vries, Linda; … - In: The European journal of health economics 24 (2023) 5, pp. 701-715

Persistent link: https://www.econbiz.de/10014328083

Costs of hospital care for strokes in India : a scoping review

Benedetto, Valerio; Cadilhac, Dominique A.; Spencer, Joseph - In: The Indian economic journal 71 (2023) 5, pp. 864-877

Persistent link: https://www.econbiz.de/10014425578